Tissue plasminogen activator, fibrin D-dimer, and insulin resistance in the relatives of patients with premature coronary artery disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 4, 2002, Pages 704-709

  Mills, Joseph D ^a   Mansfield, Michael W ^a   Grant, Peter J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Coronary artery disease; Exercise; Family history; Hemostatic factors; Insulin

Indexed keywords

D DIMER; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; FAMILY HISTORY; FITNESS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE;

ADULT; CORONARY DISEASE; FAMILY; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0036124012     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0402.105902     Document Type: Article

References (42)

1. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor
2. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study
3. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
4. Tissue plasminogen activator and risk of myocardial infarction: The Rotterdam Study
5. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study
6. Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease: A nested case-control study
7. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
8. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
9. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study
10. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: Are inflammation and fibrin turnover linked in pathogenesis?
11. Prospective study of fibrinolytic factors and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study
12. Fibrin D-dimer and coronary heart disease: Prospective study and meta-analysis
13. Banting lecture 1988: Role of insulin resistance in human disease
14. Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and atherothrombosis
15. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring: The EARS study-European Atherosclerosis Research Study Group
16. Fibrinogen in the offspring of men with premature coronary artery disease
17. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS)
18. How important is family history in ischaemic heart disease?
19. Family history as an independent risk factor for coronary artery disease
20. Increased insulin sensitivity and insulin binding to monocytes after physical training
21. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors
22. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing
23. Fibrinogen
24. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
25. Determinants of tPA antigen and associations with coronary artery disease and acute cerebrovascular disease
26. Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries
27. Plasminogen activator expression in human atherosclerotic lesions
28. Haemostasis Factors in angina pectoris: Relation to gender, age and acute-phase reaction-results of the ECAT Angina Pectoris Study Group
29. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) Complex
30. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
31. Fibrin D-dimer: A useful clinical marker of thrombogenesis?
32. Fibrin D-dimer, haemostatic factors and peripheral arterial disease
33. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients: A case-control study-The PLAT Group
34. Lifestyle and hemostatic risk factors for ischemic heart disease: The Caerphilly Study
35. Involvement of the hemostatic system in the insulin resistance syndrome: A study of 1500 patients with angina pectoris-The ECAT Angina Pectoris Study Group
36. Hyperinsulinemia as an independent risk factor for ischemic heart disease
37. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men
38. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM
39. C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives
40. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction
41. Role of haemostatic gene polymorphisms in venous and arterial thrombotic disease
42. Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans